FormosanolCAS# 101312-79-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 101312-79-2 | SDF | Download SDF |
PubChem ID | 14009037 | Appearance | Powder |
Formula | C21H24O6 | M.Wt | 372.4 |
Type of Compound | Lignans | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3S,3aR,9S,9aR)-9-(4-hydroxy-3-methoxyphenyl)-3,6-dimethoxy-1,3,3a,4,9,9a-hexahydrobenzo[f][2]benzofuran-7-ol | ||
SMILES | COC1C2CC3=CC(=C(C=C3C(C2CO1)C4=CC(=C(C=C4)O)OC)O)OC | ||
Standard InChIKey | PWKVHHWFBTXMHU-UFNANVBGSA-N | ||
Standard InChI | InChI=1S/C21H24O6/c1-24-18-7-11(4-5-16(18)22)20-13-9-17(23)19(25-2)8-12(13)6-14-15(20)10-27-21(14)26-3/h4-5,7-9,14-15,20-23H,6,10H2,1-3H3/t14-,15+,20+,21+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Formosanol Dilution Calculator
Formosanol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6853 mL | 13.4264 mL | 26.8528 mL | 53.7057 mL | 67.1321 mL |
5 mM | 0.5371 mL | 2.6853 mL | 5.3706 mL | 10.7411 mL | 13.4264 mL |
10 mM | 0.2685 mL | 1.3426 mL | 2.6853 mL | 5.3706 mL | 6.7132 mL |
50 mM | 0.0537 mL | 0.2685 mL | 0.5371 mL | 1.0741 mL | 1.3426 mL |
100 mM | 0.0269 mL | 0.1343 mL | 0.2685 mL | 0.5371 mL | 0.6713 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- PF-04691502
Catalog No.:BCC3837
CAS No.:1013101-36-4
- Zacopride hydrochloride
Catalog No.:BCC7178
CAS No.:101303-98-4
- Noreugenin
Catalog No.:BCN5827
CAS No.:1013-69-0
- PETCM
Catalog No.:BCC2360
CAS No.:10129-56-3
- 11-Chloro-2,3-dihydro-2-methyl-1H- dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
Catalog No.:BCC8431
CAS No.:1012884-46-6
- Phenserine
Catalog No.:BCC7529
CAS No.:101246-66-6
- Kushenol M
Catalog No.:BCN3310
CAS No.:101236-51-5
- Kushenol L
Catalog No.:BCN3309
CAS No.:101236-50-4
- Kushenol K
Catalog No.:BCN3448
CAS No.:101236-49-1
- IRAK inhibitor 3
Catalog No.:BCC1656
CAS No.:1012343-93-9
- Picrasidine Q
Catalog No.:BCN3182
CAS No.:101219-61-8
- IRAK inhibitor 4
Catalog No.:BCC1657
CAS No.:1012104-68-5
- Gadolinium chloride
Catalog No.:BCC7971
CAS No.:10138-52-0
- CP 376395 hydrochloride
Catalog No.:BCC7604
CAS No.:1013933-37-3
- VTP-27999 2,2,2-trifluoroacetate
Catalog No.:BCC2049
CAS No.:1013937-63-7
- GSK 0660
Catalog No.:BCC7688
CAS No.:1014691-61-2
- 5''-O-Syringoylkelampayoside A
Catalog No.:BCN4798
CAS No.:1014974-98-1
- Methyl salvionolate A
Catalog No.:BCN3475
CAS No.:1015171-69-3
- Latifolin
Catalog No.:BCN7778
CAS No.:10154-42-4
- Fmoc-D-Pro-OH
Catalog No.:BCC3540
CAS No.:101555-62-8
- Yadanzioside K
Catalog No.:BCN6714
CAS No.:101559-98-2
- Yadanzioside M
Catalog No.:BCN6712
CAS No.:101559-99-3
- trans-2,3-Dihydro-3-ethoxyeuparin
Catalog No.:BCN6923
CAS No.:1015698-14-2
- GSK 4716
Catalog No.:BCC7557
CAS No.:101574-65-6
Lignans from the Roots of Taxus wallichiana and Their alpha-Glucosidase Inhibitory Activities.[Pubmed:28581744]
J Nat Prod. 2017 Jun 23;80(6):1876-1882.
From an EtOAc-soluble extract of the roots of Taxus wallichiana, six new (1-6) and 11 known lignans were isolated. The structures of the new compounds were elucidated based on interpretation of spectroscopic data. (+)-7'-epi-Tsugacetal (1) is a rare aryltetralin-type lignan having a cis-orientation of H-7' and H-8'. Compounds 3-6 were identified as the first naturally occurring tetrahydrofuranoid lignans having a cis-orientation of H-7 and H-8. All tested compounds were found to possess alpha-glucosidase inhibitory activity, with Formosanol (9) showing the most potent effect with an IC50 value of 35.3 muM.